HALOZYME THERAPEUTICS, INC. HALO Income Statement

Halozyme therapeutics, inc. (HALO)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Total revenues
25,354	53,665	46,230	39,148	56,949	60,232	25,556	35,202	30,872	189,564	63,731	33,750	29,568	39,003	31,853	33,336	42,499	52,227	20,780	43,384	18,666	30,377	14,606	18,385	11,966	12,498	16,013	14,454	11,834	21,793	5,334	7,757	7,440	2,411	22,942	23,188	7,543	3,396	3,213
Operating expenses:
Cost of product sales
5,787	16,687	22,333	1,877	4,649	5,622	626	836	3,052	7,488	8,332	7,788	7,544	8,002	9,134	8,308	7,762	8,427	6,180	8,144	6,494	6,147	5,141	5,924	5,520	3,540	683	1,284	739	653	226	143	70	56	11	178	11	7	83
Research and development
10,158	45,111	30,455	33,910	31,328	36,650	35,540	40,086	37,976	41,376	33,993	38,339	36,935	41,349	33,863	35,530	40,100	27,746	27,611	21,195	16,684	19,728	19,904	18,649	21,415	20,926	25,689	27,991	22,034	18,567	19,503	16,081	15,891	14,916	13,514	15,347	13,785	12,448	11,924
Selling, general and administrative
12,632	23,929	17,979	17,338	18,006	18,031	14,864	14,353	13,556	14,771	13,329	13,101	12,615	12,227	11,599	11,221	10,806	10,589	10,226	9,814	9,399	8,353	8,587	8,752	10,250	9,356	8,135	7,300	7,556	6,978	5,634	5,580	6,618	5,866	4,263	4,567	3,405	3,374	3,357
Total operating expenses
28,577	85,727	70,767	53,125	53,983	60,303	51,030	55,275	54,584	63,635	55,654	59,228	57,094	61,578	54,596	55,059	58,668	46,762	44,017	39,153	32,577	34,228	33,632	33,325	37,185	33,822	34,507	36,575	30,329	26,199	25,364	21,805	22,580	20,839	17,789	20,093	17,203	15,830	15,365
Operating (loss) income
-3,223	-32,062	-24,537	-13,977	2,966	-71	-25,474	-20,073	-23,712	125,929	8,077	-25,478	-27,526	-22,575	-22,743	-21,723	-16,169	5,465	-23,237	4,231	-13,911	-3,851	-19,026	-14,940	-25,219	-21,324	-18,494	-22,121	-18,495	-4,406	-20,029	-14,048	-15,140	-18,428	5,152	3,095	-9,659	-12,433	-12,152
Other income (expense):
Interest income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20	23	-	-
Investment and other income, net
2,479	1,333	1,613	1,983	2,057	2,017	1,910	1,983	1,668	1,080	790	435	287	366	334	397	229	155	78	87	102	-45	122	118	47	64	52	58	55	0	23	26	21	-	12	-	-	24	1
Interest expense
5,348	3,731	2,078	2,613	3,205	3,755	4,286	4,770	5,230	5,458	5,538	5,540	5,448	5,599	5,253	5,249	3,876	1,302	1,301	1,299	1,299	1,378	1,376	1,451	1,376	727	850	849	848	0	0	0	0	-	-	-	-	-	-
Net (loss) income before income taxes
-6,092	-34,460	-25,002	-14,607	1,818	-1,809	-27,850	-22,860	-27,274	121,551	3,329	-30,583	-32,687	-27,808	-27,662	-26,575	-19,816	-	-24,460	3,019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense
11	-63	13	17	22	317	0	33	187	-2,331	580	180	210	-422	1,284	300	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-6,103	-34,397	-25,015	-14,624	1,796	-2,126	-27,850	-22,893	-27,461	123,882	2,749	-30,763	-32,897	-27,386	-28,946	-26,875	-19,816	4,318	-24,460	3,019	-15,108	-5,274	-20,280	-16,273	-26,548	-21,987	-19,292	-22,912	-19,288	-4,405	-20,005	-14,021	-15,119	-18,415	5,165	3,116	-9,635	-12,409	-12,150
Net (loss) income per share:
Basic and diluted (usd per share)
-0.04	-0.24	-0.17	-0.10	0.01	-	-0.19	-0.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.22	0.00	-0.17	-0.20	-0.17	0.00	-0.18	-0.13	-0.14	0.00	0.05	0.03	-0.10	-	-
Net income (loss) per share, Basic
-	-	-	-	-	-	-	-	-0.19	0.93	0.02	-0.23	-0.26	-0.21	-0.23	-0.21	-0.16	0.04	-0.19	0.02	-0.12	-	-0.16	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.13	-0.13
Net income (loss) per share, Diluted
-	-	-	-	-	-	-	-	-0.19	-	0.02	-	-	-	-0.23	-	-	-	-	0.02	-	-	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.13	-0.13
Shares used in computing net (loss) income per share:
Basic and diluted (in shares)
137,186	141,026	146,136	145,411	144,743	-	143,949	143,568	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	118,943	113,552	112,765	112,486	112,417	112,349	112,305	112,063	107,589	-	-	-	100,927	-	-
Shares used in computing basic net income (loss) per share
-	-	-	-	-	-	-	-	142,656	141,858	141,190	134,013	128,615	128,129	128,154	127,958	127,615	128,452	126,921	126,144	125,299	-	124,041	123,710	-	-	-	-	-	-	-	-	-	-	103,223	102,671	-	93,626	91,766
Shares used in computing diluted net income (loss) per share
-	-	-	-	-	-	-	-	142,656	-	143,236	-	-	-	128,154	-	-	-	-	134,507	-	-	-	123,710	-	-	-	-	-	-	-	-	-	-	105,009	104,393	-	93,626	91,766
Comprehensive Loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,165	3,116	-9,635	-	-
Royalties
Total revenues
16,822	17,230	16,609	18,107	17,953	19,338	18,710	19,989	20,944	17,668	17,119	14,738	13,982	14,289	13,036	12,272	11,387	9,544	8,274	6,382	6,775	4,043	2,895	1,688	799	33	0	0	0	-	-	-	-	-	-	-	-	-	-
Product sales, net
Total revenues
8,147	22,693	29,205	5,760	8,390	10,681	6,269	4,483	6,801	12,593	13,589	12,780	11,434	13,422	13,331	13,699	12,940	13,579	10,301	12,342	9,860	10,144	9,617	9,494	8,568	9,805	10,025	3,100	1,509	1,459	715	524	187	348	1,156	165	165	98	199
Collaborative Agreements [Member]
Total revenues
385	13,742	416	15,281	30,606	30,213	577	10,730	3,127	159,303	33,023	6,232	4,152	11,292	5,486	7,365	18,172	29,104	2,205	24,660	2,031	16,190	2,094	7,203	2,599	2,660	5,988	11,354	10,325	20,334	4,618	7,232	7,252	2,062	21,785	23,023	7,378	3,298	3,013